Antonio Salar

6.7k total citations
153 papers, 3.0k citations indexed

About

Antonio Salar is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Antonio Salar has authored 153 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Pathology and Forensic Medicine, 63 papers in Oncology and 58 papers in Genetics. Recurrent topics in Antonio Salar's work include Lymphoma Diagnosis and Treatment (104 papers), Chronic Lymphocytic Leukemia Research (48 papers) and Viral-associated cancers and disorders (29 papers). Antonio Salar is often cited by papers focused on Lymphoma Diagnosis and Treatment (104 papers), Chronic Lymphocytic Leukemia Research (48 papers) and Viral-associated cancers and disorders (29 papers). Antonio Salar collaborates with scholars based in Spain, United Kingdom and United States. Antonio Salar's co-authors include Eva González‐Barca, Carlos Montalbán, Alberto Fernández de Sevilla, Josep‐María Ribera, Gregor Verhoef, Hans Erik Johnsen, Armando López‐Guillermo, Francesca Gaia Rossi, Eva Domingo‐Doménech and Juan‐Manuel Sancho and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Antonio Salar

146 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Salar Spain 28 1.8k 1.2k 819 574 519 153 3.0k
Soon Thye Lim Singapore 27 1.7k 0.9× 1.4k 1.2× 457 0.6× 389 0.7× 563 1.1× 123 2.6k
Stein Kvaløy Norway 31 1.7k 0.9× 1.5k 1.2× 634 0.8× 543 0.9× 370 0.7× 94 3.2k
Jean Gabarre France 31 2.4k 1.4× 2.2k 1.8× 694 0.8× 751 1.3× 429 0.8× 81 3.3k
Bertram Glaß Germany 26 2.4k 1.4× 2.2k 1.8× 1000 1.2× 944 1.6× 750 1.4× 102 4.1k
Dai Chihara United States 25 1.2k 0.7× 932 0.8× 662 0.8× 352 0.6× 477 0.9× 128 2.1k
Mark Hertzberg Australia 28 1.5k 0.9× 1.7k 1.4× 894 1.1× 273 0.5× 605 1.2× 166 3.5k
John P. Greer United States 31 1.5k 0.9× 1.3k 1.1× 556 0.7× 379 0.7× 772 1.5× 119 3.3k
Véronique Meignin France 35 1.3k 0.7× 1.9k 1.5× 444 0.5× 389 0.7× 581 1.1× 111 3.6k
William R. Macon United States 39 3.6k 2.0× 2.4k 2.0× 1.3k 1.6× 761 1.3× 921 1.8× 139 4.9k
Emmanuel Bachy France 26 1.2k 0.7× 1.3k 1.1× 450 0.5× 204 0.4× 379 0.7× 185 2.3k

Countries citing papers authored by Antonio Salar

Since Specialization
Citations

This map shows the geographic impact of Antonio Salar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Salar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Salar more than expected).

Fields of papers citing papers by Antonio Salar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Salar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Salar. The network helps show where Antonio Salar may publish in the future.

Co-authorship network of co-authors of Antonio Salar

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Salar. A scholar is included among the top collaborators of Antonio Salar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Salar. Antonio Salar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bento, Leyre, Blanca Sánchez‐González, Francesc García‐Pallarols, et al.. (2025). From Clinical Perception to Implicit Bias: Understanding Personality Traits in Lymphoma Patients. Cancers. 17(11). 1743–1743.
2.
Andrade‐Campos, Marcio, Blanca Sánchez‐González, Concepción Fernández‐Rodríguez, et al.. (2024). Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas. Cancers. 16(2). 321–321. 1 indexed citations
3.
4.
Martı́n, Alejandro, Mónica Baile, Guillermo Rodríguez‐Domínguez, et al.. (2023). Lenalidomide in combination with R‐ESHAP in patients with relapsed or refractory diffuse large B‐cell lymphoma: A phase 2 study from GELTAMO. British Journal of Haematology. 203(2). 202–211.
5.
Bento, Leyre, Oliver Vögler, Josep Muncunill, et al.. (2022). Screening for Prognostic microRNAs Associated with Treatment Failure in Diffuse Large B Cell Lymphoma. Cancers. 14(4). 1065–1065. 9 indexed citations
6.
Dickinson, Michael, Carmelo Carlo‐Stella, Franck Morschhauser, et al.. (2021). Glofitamab Monotherapy Provides Durable Responses after Fixed-Length Dosing in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (pts). Blood. 138(Supplement 1). 2478–2478. 9 indexed citations
7.
Bento, Leyre, Blanca Sánchez‐González, Francesc García‐Pallarols, et al.. (2021). Analysis of Personality Traits in Patients with Hodgkin Lymphoma. Journal of Clinical Medicine. 10(8). 1631–1631. 1 indexed citations
8.
Rodríguez‐Sevilla, Juan José, Diego A. Rodríguez, Antonio Salar, et al.. (2020). CT imaging of pulmonary embolism in patients with COVID-19 pneumonia: a retrospective analysis. European Radiology. 31(4). 1915–1922. 23 indexed citations
9.
Muntañola, Ana, Tycho Baumann, A Caballero, et al.. (2020). Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group. Annals of Hematology. 99(7). 1627–1634. 3 indexed citations
10.
11.
Salar, Antonio. (2018). Gastric MALT lymphoma and Helicobacter pylori. Medicina Clínica (English Edition). 152(2). 65–71. 27 indexed citations
12.
Peñalver, Francisco Javier, Julio Delgado, Javier Loscertales, et al.. (2015). Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma. European Journal Of Haematology. 96(5). 532–540. 1 indexed citations
13.
Gimeno, Eva, Miquel Gómez, Juan R. González, et al.. (2011). NT-proBNP: A cardiac biomarker to assess prognosis in non-Hodgkin lymphoma. Leukemia Research. 35(6). 715–720. 31 indexed citations
14.
Montalbán, Carlos, Víctor Abraira, Luca Arcaini, et al.. (2011). Stratification Approach for Splenic Marginal Zone Lymphoma Based on Hemoglobin, Platelet Count, High LDH and Extrahilar Lymphadenopathy: The HPLL/ABC System. Blood. 118(21). 1583–1583. 2 indexed citations
15.
López‐Guillermo, Armando, Dolores Caballero, Miguel Canales, et al.. (2011). Clinical practice guidelines for first-line/after-relapse treatment of patients with follicular lymphoma. Leukemia & lymphoma. 52(sup3). 1–14. 16 indexed citations
16.
Gimeno, Eva, Blanca Sánchez‐González, Alberto Álvarez‐Larrán, et al.. (2010). Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma. Leukemia Research. 35(3). 358–362. 16 indexed citations
17.
Ferrán, Marta, Fernando Gallardo, Antonio Salar, et al.. (2006). Granulomatous Dermatitis with Enlarged Histiocytes: A Characteristic Pattern of Granulocyte Colony-Stimulating Factor. Dermatology. 212(2). 188–193. 17 indexed citations
18.
Ahmadi, Farzane, Antonio Salar, & Soghrat Faghihzadeh. (2004). Quality of life in Zahedan elderly population. SHILAP Revista de lepidopterología. 36 indexed citations
19.
20.
Salar, Antonio, Jorge Sierra, J. Marín, et al.. (2001). Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens. Bone Marrow Transplantation. 27(4). 405–412. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soon Thye Lim Breakdown of academic impact, for papers by Stein Kvaløy Breakdown of academic impact, for papers by Jean Gabarre Breakdown of academic impact, for papers by Bertram Glaß Breakdown of academic impact, for papers by Dai Chihara Breakdown of academic impact, for papers by Mark Hertzberg Breakdown of academic impact, for papers by John P. Greer Breakdown of academic impact, for papers by Véronique Meignin Breakdown of academic impact, for papers by William R. Macon Breakdown of academic impact, for papers by Emmanuel Bachy
Rankless by CCL
2026